Zymeworks (ZYME) EBT Margin (2021 - 2026)

Zymeworks (ZYME) reported EBT Margin of 1924.96% for Q1 2026, down 184329.0% on a YoY basis from N/an in Q1 2025, and down 16.72% sequentially from 1649.26% in Q4 2025.

Zymeworks (ZYME) EBT Margin (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of EBT Margin data on file, last reported at 1924.96% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 184329.0% year-over-year to 1924.96%; the trailing twelve-month figure through Mar 2026 stood at 127.94% (down 1317.0% YoY), and the FY2025 full-year result was 75.26%, up 7756.0% from the prior year.
  • EBT Margin fell to 1924.96% in Q1 2026, from 1649.26% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 98.6% in Q4 2022 to a low of 3794.31% in Q1 2022.
  • A 5-year average of 719.14% and a median of 185.15% in 2024 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin surged 372977 bps in 2023 and tumbled 184329 bps in 2026, its largest moves.
  • Tracing ZYME's EBT Margin over 5 years: stood at 98.6% in 2022, then plunged by 215 bps to 113.46% in 2023, then surged by 49 bps to 57.33% in 2024, then slumped by 2777 bps to 1649.26% in 2025, then decreased by 17 bps to 1924.96% in 2026.
  • Business Quant data shows ZYME's EBT Margin at 1924.96% in Q1 2026, 1649.26% in Q4 2025, and 66.15% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zymeworks 1.73 Bn 1.36 Bn - -1,924.96%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,924.96%
Dec 31, 2025 -1,649.26%
Sep 30, 2025 -66.15%
Jun 30, 2025 4.37%
Mar 31, 2025 -81.67%
Dec 31, 2024 -57.33%
Sep 30, 2024 -185.15%
Jun 30, 2024 -195.49%
Mar 31, 2024 -314.84%
Dec 31, 2023 -113.46%
Sep 30, 2023 -167.07%
Jun 30, 2023 -706.91%
Mar 31, 2023 -64.54%
Dec 31, 2022 98.60%
Sep 30, 2022 -1,819.65%
Jun 30, 2022 -1,187.58%
Mar 31, 2022 -3,794.31%
Dec 31, 2021 -506.54%
Sep 30, 2021 -1,360.98%